FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024703404> ?p ?o ?g. }

• W3024703404 abstract "GuanXinNing tablet (GXNT), a traditional Chinese patent medicine, has been found to have remarkable antithrombotic effects and can effectively inhibit pro-thrombotic factors in previous studies. However, the mechanism of its antithrombotic effects remains little known.In this study, we first determined and identified the sources of each main compound in GXNT using liquid chromatography-mass spectrometry (LC-MS). Through the approach of network pharmacology, we predicted the action targets of the active components, mapped the target genes related to thrombus, and obtained potential antithrombotic targets for active ingredients. We then performed gene ontology (GO) enrichment analyses and KEGG signaling pathway analyses for the action targets, and constructed networks of active component-target and active component-target-pathway for GXNT. Additionally, we evaluated the pharmacodynamic effects of GXNT on thrombus using the rat thrombus model induced by FeCl3, observed the effects of antiplatelet aggregation via platelet assay, and further verified the results predicted by network pharmacology via Western blot.In total, 14 active ingredients were identified in GXNT, and 83 action targets were predicted, 17 of which are antithrombotic targets that potentially participate in processes including response to oxidative stress and positive regulation of blood vessel endothelial cell migration. KEGG pathway analyses revealed that the predicted action targets were involved in multiple signal pathways, such as MAPK, IL-17, and platelet activation. Pharmacodynamics study found that GXNT could significantly reduce the thrombus length and weight, lower platelet aggregation function, and decrease the levels of Fbg and PAI-1. In addition, GXNT could significantly increase 6-keto-PGF1α content and regulate the ratio of TXB2/6-keto-PGF1α, while not having dramatic effects on TXB2. GXNT was also observed to visibly inhibit maximum platelet aggregation. Herein, we further studied the thrombus-related MAPKs signaling pathway and found that GXNT could significantly reduce the phosphorylation levels of p38MAPK, ERK, and JNK proteins in platelet.This study revealed the pharmacodynamic material basis of GXNT and its potential multicomponent-multitarget-multipath pharmacological effects, confirmed the antithrombotic effects of GXNT, and showed that its mechanism may be related to inhibiting phosphorylation of p38, ERK, and JNK proteins in MAPKs signaling pathway, partially verifying the results from network pharmacology. The results from this study could provide a theoretical basis for the development and clinical application of GXNT." @default.
• W3024703404 created "2020-05-21" @default.
• W3024703404 creator A5008465840 @default.
• W3024703404 creator A5016290661 @default.
• W3024703404 creator A5023264172 @default.
• W3024703404 creator A5024964740 @default.
• W3024703404 creator A5026602171 @default.
• W3024703404 creator A5042079141 @default.
• W3024703404 creator A5042353754 @default.
• W3024703404 creator A5056817088 @default.
• W3024703404 creator A5084609065 @default.
• W3024703404 date "2020-05-13" @default.
• W3024703404 modified "2023-10-10" @default.
• W3024703404 title "Network Pharmacology-Based Approach Uncovers the Mechanism of GuanXinNing Tablet for Treating Thrombus by MAPKs Signal Pathway" @default.
• W3024703404 cites W1438299080 @default.
• W3024703404 cites W1471481200 @default.
• W3024703404 cites W1586532694 @default.
• W3024703404 cites W1930451082 @default.
• W3024703404 cites W1951855398 @default.
• W3024703404 cites W1972147469 @default.
• W3024703404 cites W1984241869 @default.
• W3024703404 cites W1988212011 @default.
• W3024703404 cites W2000312990 @default.
• W3024703404 cites W2014198498 @default.
• W3024703404 cites W2033591223 @default.
• W3024703404 cites W2054004741 @default.
• W3024703404 cites W2054266243 @default.
• W3024703404 cites W2088160263 @default.
• W3024703404 cites W2120628764 @default.
• W3024703404 cites W2150314819 @default.
• W3024703404 cites W2159172969 @default.
• W3024703404 cites W2168938595 @default.
• W3024703404 cites W2286982004 @default.
• W3024703404 cites W2292914888 @default.
• W3024703404 cites W2314559073 @default.
• W3024703404 cites W2340094283 @default.
• W3024703404 cites W2501900876 @default.
• W3024703404 cites W2531924524 @default.
• W3024703404 cites W2561212449 @default.
• W3024703404 cites W2581238721 @default.
• W3024703404 cites W2588088259 @default.
• W3024703404 cites W2622245931 @default.
• W3024703404 cites W2734391791 @default.
• W3024703404 cites W2789964320 @default.
• W3024703404 cites W2791994075 @default.
• W3024703404 cites W2792209933 @default.
• W3024703404 cites W2792574684 @default.
• W3024703404 cites W2793914951 @default.
• W3024703404 cites W2793927076 @default.
• W3024703404 cites W2794065164 @default.
• W3024703404 cites W2804946564 @default.
• W3024703404 cites W2806076907 @default.
• W3024703404 cites W978308701 @default.
• W3024703404 doi "https://doi.org/10.3389/fphar.2020.00652" @default.
• W3024703404 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7237702" @default.
• W3024703404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32477130" @default.
• W3024703404 hasPublicationYear "2020" @default.
• W3024703404 type Work @default.
• W3024703404 sameAs 3024703404 @default.
• W3024703404 citedByCount "12" @default.
• W3024703404 countsByYear W30247034042021 @default.
• W3024703404 countsByYear W30247034042022 @default.
• W3024703404 countsByYear W30247034042023 @default.
• W3024703404 crossrefType "journal-article" @default.
• W3024703404 hasAuthorship W3024703404A5008465840 @default.
• W3024703404 hasAuthorship W3024703404A5016290661 @default.
• W3024703404 hasAuthorship W3024703404A5023264172 @default.
• W3024703404 hasAuthorship W3024703404A5024964740 @default.
• W3024703404 hasAuthorship W3024703404A5026602171 @default.
• W3024703404 hasAuthorship W3024703404A5042079141 @default.
• W3024703404 hasAuthorship W3024703404A5042353754 @default.
• W3024703404 hasAuthorship W3024703404A5056817088 @default.
• W3024703404 hasAuthorship W3024703404A5084609065 @default.
• W3024703404 hasBestOaLocation W30247034041 @default.
• W3024703404 hasConcept C104317684 @default.
• W3024703404 hasConcept C111113717 @default.
• W3024703404 hasConcept C112705442 @default.
• W3024703404 hasConcept C126322002 @default.
• W3024703404 hasConcept C150194340 @default.
• W3024703404 hasConcept C152724338 @default.
• W3024703404 hasConcept C185592680 @default.
• W3024703404 hasConcept C202751555 @default.
• W3024703404 hasConcept C2776120743 @default.
• W3024703404 hasConcept C2777015399 @default.
• W3024703404 hasConcept C2781362458 @default.
• W3024703404 hasConcept C2987395477 @default.
• W3024703404 hasConcept C3018697912 @default.
• W3024703404 hasConcept C55493867 @default.
• W3024703404 hasConcept C57074206 @default.
• W3024703404 hasConcept C62478195 @default.
• W3024703404 hasConcept C71924100 @default.
• W3024703404 hasConcept C89560881 @default.
• W3024703404 hasConcept C98274493 @default.
• W3024703404 hasConceptScore W3024703404C104317684 @default.
• W3024703404 hasConceptScore W3024703404C111113717 @default.
• W3024703404 hasConceptScore W3024703404C112705442 @default.
• W3024703404 hasConceptScore W3024703404C126322002 @default.
• W3024703404 hasConceptScore W3024703404C150194340 @default.
• W3024703404 hasConceptScore W3024703404C152724338 @default.
• W3024703404 hasConceptScore W3024703404C185592680 @default.

• next